- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Environmental and Public Health
Volume 2011 (2011), Article ID 850105, 10 pages
Thyroid Cancer Incidence in New Jersey: Time Trend, Birth Cohort and Socioeconomic Status Analysis (1979–2006)
Cancer Epidemiology Services, New Jersey Department of Health and Senior Services, P.O. Box 369, Trenton, NJ 08625-0369, USA
Received 10 May 2011; Accepted 15 September 2011
Academic Editor: T. Zheng
Copyright © 2011 Lisa M. Roche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- National Cancer Institute, “SEER Cancer Statistics Review, 1975–2006,” Edited by Horner MJ, Ries LAG, Krapcho M., Bethesda, Md, USA, 2009, http://seer.cancer.gov/csr/1975_2006.
- U.S. Cancer Statistics Working Group, “United States Cancer Statistics 1999–2005 incidence and mortality web-based report,” Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2009, http://apps.nccd.cdc.gov/uscs/.
- X. Niu, S. S. Burger, K. Pawlish, and K. A. Henry, Cancer Incidence and Mortality in New Jersey 2002–2006, Cancer Epidemiology Services, New Jersey Department of Health and Senior Services, Trenton, NJ, USA, 2009.
- E. Ron and A. B. Schneider, “Thyroid cancer,” in Cancer Epidemiology and Prevention, D. Schottenfeld and J. F. Fraumeni, Eds., pp. 975–994, Oxford University Press, New York, NY, USA, 3rd edition, 2006.
- E. Ron, J. H. Lubin, R. E. Shore et al., “Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies,” Radiation Research, vol. 141, no. 3, pp. 259–277, 1995.
- J. L. Lyon, S. C. Alder, M. B. Stone et al., “Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data,” Epidemiology, vol. 17, no. 6, pp. 604–614, 2006.
- E. S. Gilbert, R. Tarone, A. Bouville, and E. Ron, “Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests,” Journal of the National Cancer Institute, vol. 90, no. 21, pp. 1654–1660, 1998.
- R. A. Kerber, J. E. Till, S. L. Simon et al., “A cohort study of thyroid disease in relation to fallout from nuclear weapons testing,” Journal of the American Medical Association, vol. 270, no. 17, pp. 2076–2082, 1993.
- C. Zhu, T. Zheng, B. A. Kilfoy et al., “A birth cohort analysis of the incidence of papillary thyroid cancer in the united states, 1973–2004,” Thyroid, vol. 19, no. 10, pp. 1061–1066, 2009.
- T. Zheng, T. R. Holford, Y. Chen et al., “Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992,” International Journal of Cancer, vol. 67, no. 4, pp. 504–509, 1996.
- L. M. Pottern, B. J. Stone, N. E. Day, L. W. Pickle, and J. F. Fraumeni, “Thyroid cancer in Connecticut, 1935–1975: an analysis by cell type,” American Journal of Epidemiology, vol. 112, pp. 764–774, 1980.
- W. Weiss, “Changing incidence of thyroid cancer,” Journal of the National Cancer Institute, vol. 62, no. 5, pp. 1137–1142, 1979.
- W. D. T. Kent, S. F. Hall, P. A. Isotalo, R. L. Houlden, R. L. George, and P. A. Groome, “Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease,” Canadian Medical Association Journal, vol. 177, no. 11, pp. 1357–1361, 2007.
- L. Davies and H. G. Welch, “Increasing incidence of thyroid cancer in the United States, 1973–2002,” Journal of the American Medical Association, vol. 295, no. 18, pp. 2164–2167, 2006.
- A. Y. Chen, A. Jemal, and E. M. Ward, “Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005,” Cancer, vol. 115, no. 16, pp. 3801–3807, 2009.
- L. Enewold, K. Zhu, E. Ron et al., “Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 3, pp. 784–791, 2009.
- I. Kawachi and C. Kroenke, “Socioeconomic disparities in cancer incidence and mortality,” in Cancer Epidemiology and Prevention, D. Schottenfeld and J. F. Fraumeni, Eds., pp. 174–188, Oxford University Press, New York, NY, USA, 3rd edition, 2006.
- B. L. Sprague, S. Warren Andersen, and A. Trentham-Dietz, “Thyroid cancer incidence and socioeconomic indicators of health care access,” Cancer Causes and Control, vol. 19, no. 6, pp. 585–593, 2008.
- L. G. T. Morris, A. G. Sikora, D. Myssiorek, and M. D. DeLacure, “The basis of racial differences in the incidence of thyroid cancer,” Annals of Surgical Oncology, vol. 15, no. 4, pp. 1169–1176, 2008.
- C. Iribarren, T. Haselkorn, I. S. Tekawa, and G. D. Friedman, “Cohort study of thyroid cancer in a San Francisco bay area population,” International Journal of Cancer, vol. 93, no. 5, pp. 745–750, 2001.
- T. Haselkorn, L. Bernstein, S. Preston-Martin, W. Cozen, and W. J. Mack, “Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995,” Cancer Causes and Control, vol. 11, no. 2, pp. 163–170, 2000.
- T. Haselkorn, S. L. Stewart, and P. L. Horn-Ross, “Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The Bay Area thyroid cancer study,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 2, pp. 144–150, 2003.
- L. N. Kolonel, J. H. Hankin, L. R. Wilkens, F. H. Fukunaga, and M. W. Hinds, “An epidemiologic study of thyroid cancer in Hawaii,” Cancer Causes and Control, vol. 1, no. 3, pp. 223–234, 1990.
- E. Ron, R. A. Kleinerman, J. D. Boice, V. A. LiVolsi, J. T. Flannery, and J. F. Fraumeni, “A population-based case-control study of thyroid cancer,” Journal of the National Cancer Institute, vol. 79, pp. 1–12, 1987.
- J. M. Oakes and J. S. Kaufman, Eds., Methods in Social Epidemiology, Josey-Bass, San Francisco, Calif, USA, 2006.
- K. Yost, C. Perkins, R. Cohen, C. Morris, and W. Wright, “Socioeconomic status and breast cancer incidence in California for different race/ethnic groups,” Cancer Causes and Control, vol. 12, no. 8, pp. 703–711, 2001.
- J. Barry and N. Breen, “The importance of place of residence in predicting late-stage diagnosis of breast or cervical cancer,” Health and Place, vol. 11, no. 1, pp. 15–29, 2005.
- A. C. Klassen, F. C. Curriero, J. H. Hong et al., “The role of area-level influences on prostate cancer grade and stage at diagnosis,” Preventive Medicine, vol. 39, no. 3, pp. 441–448, 2004.
- A. Fritz, C. Percy, A. Jack, et al., International Classification of Diseases for Oncology, World Health Organization, Geneva, Switzerland, 3rd edition, 2000.
- J. L. Young Jr., S. D. Roffers, L. A. G. Ries, A. G. Fritz, and A. A. Hurlbut, SEER Summary Staging Manual—2000: Codes and Coding Instructions, NIH Publication Number 01-4969, National Cancer Institute, Bethesda, Md, USA, 2001.
- Collaborative Staging Task Force of the American Joint Committee on Cancer, “Collaborative Staging Manual and Coding Instructions, version 01.04.00,” NIH Publication Number 04-5496. Jointly published by Chicago, IL: American Joint Committee on Cancer and Bethesda, MD: U.S. Department of Health and Human Services, 2004.
- Surveillance, Epidemiology, and End Results (SEER) Program, “SEER Database: populations–Total U.S. (1969–2006),” National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2008, http://seer.cancer.gov/popdata/.
- Surveillance Research Program, “National Cancer Institute: SEER software, version 6.5.2.,” 2009, http://www.seer.cancer.gov/seerstat/.
- Statistical Research and Applications Branch, National Cancer Institute, Joinpoint Regression Program, version 3.4.2, 2010.
- Statistical Research and Applications Branch, National Cancer Institute, “Average Annual Percent Change (AAPC),” 2010, http://srab.cancer.gov/joinpoint/aapc.html.
- H. J. Kim, M. P. Fay, E. J. Feuer, and D. N. Midthune, “Permutation tests for joinpoint regression with applications to cancer rates,” Statistics in Medicine, vol. 19, no. 3, pp. 335–351, 2000.
- S. H. Moolgavkar, J. A. H. Lee, and R. G. Stevens, “Analysis of vital statistics data,” in Modern Epidemiology, K. J. Rothman and S. Greenland, Eds., pp. 481–497, Lippincott-Raven, Philadelphia, Pa, USA, 2nd edition, 1998.
- L. C. Messer, B. A. Laraia, J. S. Kaufman et al., “The development of a standardized neighborhood deprivation index,” Journal of Urban Health, vol. 83, no. 6, pp. 1041–1062, 2006.
- SAS Institute Inc, “SAS/STAT(R) 9.22 User's Guide,” 2010, http://support.sas.com/documentation/cdl_main/.
- M. P. Fay, R. C. Tiwari, E. J. Feuer, and Z. Zou, “Estimating average annual percent change for disease rates without assuming constant change,” Biometrics, vol. 62, no. 3, pp. 847–854, 2006.
- U.S. Census Bureau, “Small Area Health Insurance Estimates, 2005 Health Insurance Coverage Status for Counties,” 2010, http://www.census.gov/did/www/sahie/data/2005/index.html.
- U.S. Census Bureau, “Small Area Health Insurance Estimates, 2006 Health Insurance Coverage Status for Counties,” 2010, http://www.census.gov/did/www/sahie/data/2006/index.html.
- National Council on Radiation Protection and Measurements, “Ionizing radiation exposure of the population of the United States: recommendations of the National Council on Radiation Protection and Measurements,” Tech. Rep. 160, Bethesda, Md, USA, 2009.
- F. A. Mettler, B. R. Thomadsen, M. Bhargavan et al., “Medical radiation exposure in the U.S. in 2006: Preliminary results,” Health Physics, vol. 95, no. 5, pp. 502–507, 2008.
- R. Smith-Bindman, J. Lipson, R. Marcus et al., “Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer,” Archives of Internal Medicine, vol. 169, no. 22, pp. 2078–2086, 2009.
- R. Fazel, H. M. Krumholz, Y. Wang et al., “Exposure to low-dose ionizing radiation from medical imaging procedures,” The New England Journal of Medicine, vol. 361, no. 9, pp. 849–857, 2009.
- International Commission on Radiological Protection, “The 2007 recommendations of the international commission on radiological protection, ICRP publication 103,” Annals of the ICRP, vol. 37, pp. 1–322, 2007.
- A. Berrington De González, M. Mahesh, K. P. Kim et al., “Projected Cancer Risks from Computed Tomographic Scans Performed in the United States in 2007,” Archives of Internal Medicine, vol. 169, no. 22, pp. 2071–2077, 2009.
- D. B. Richardson, “Exposure to ionizing radiation in adulthood and thyroid cancer incidence,” Epidemiology, vol. 20, no. 2, pp. 181–187, 2009.
- Y. Hayashi, F. Lagarde, N. Tsuda et al., “Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk,” Cancer, vol. 116, no. 7, pp. 1646–1655, 2010.
- C. L. Meinhold, E. Ron, S. J. Schonfeld et al., “Nonradiation risk factors for thyroid cancer in the US radiologic technologists study,” American Journal of Epidemiology, vol. 171, no. 2, pp. 242–252, 2010.
- C. DeNavas-Walt, B. D. Procter, and J. Smith, “U.S. Census Bureau Current population reports, P60-233, Income, Poverty, and Health Insurance Coverage in the United States: 2006,” Washington, DC: U.S. Government Printing Office, 2010, http://www.census.gov/prod/2007pubs/p60-233.pdf.